Targeting Human C-Type Lectin-Like Molecule-1 (CLL1) with a Bispecific Antibody for Acute Myeloid Leukemia Immunotherapy

Acute myeloid leukemia (AML), the most common acute adult leukemia and the second most common pediatric leukemia, still has a poor prognosis. Human C-type lectin-like molecule-1 (CLL1) is a recently identified myeloid lineage restricted cell surface marker, which is overexpressed in over 90% of AML...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Angew Chem Int Ed Engl
Main Authors: Lu, Hua, Zhou, Quan, Deshmukh, Vishal, Phull, Hardeep, Ma, Jennifer, Tardif, Virginie, Naik, Rahul R., Bouvard, Claire, Zhang, Yong, Choi, Seihyun, Lawson, Brian R., Zhu, Shoutian, Kim, Chan Hyuk, Schultz, Peter G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4280064/
https://ncbi.nlm.nih.gov/pubmed/25056598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201405353
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados